KRAS and cancer: The distributions of these mutations were similar across both cancer histologies, with the exception of oncogenic KRAS mutations, which were almost exclusive to LUAD apart from a single patient with squamous cell carcinoma with a KRASG12C mutation (Fig. 1C and D).